2014
Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities
Heimer R, Eritsyan K, Barbour R, Levina OS. Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities. BMC Infectious Diseases 2014, 14: s12. PMID: 25253447, PMCID: PMC4178532, DOI: 10.1186/1471-2334-14-s6-s12.Peer-Reviewed Original ResearchConceptsHepatitis C virusRespondent-driven samplingHIV-1Hepatitis C virus (HCV) seroprevalencePositive HCV serostatusInjection drug useLarger social network sizeHarm reduction programsHCV-positive serostatusBetter prevention programsHCV prevalenceHCV serostatusHCV epidemicMean ageC virusInjection paraphernaliaVirus seroprevalenceSerological testingRisk populationsBlood specimensCity-level factorsPWIDDrug usePrevention programsLonger duration
2013
Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study
Eritsyan K, Heimer R, Barbour R, Odinokova V, White E, Rusakova MM, Smolskaya TT, Levina OS. Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study. BMJ Open 2013, 3: e002645. PMID: 23794559, PMCID: PMC3686233, DOI: 10.1136/bmjopen-2013-002645.Peer-Reviewed Original ResearchHIV prevalenceActive IDUsHepatitis C virus infectionC virus infectionCross-sectional studyTarget sample sizeHarm reduction programsCross-sectional surveyRespondent-driven samplingHepatitis CPrevalent infectionHIV knowledgeHIV epidemicSerological testingVirus infectionDrug treatmentInjection riskHIVEnzyme immunoassayNetwork-level variablesPrevalenceSexual behaviorIDUsProtective behaviorsHierarchical regression models